AC Immune
Alexis Kiefer is a seasoned professional with extensive experience in data protection, governance, and business management. Currently serving as a Member of the Board at ASDPO and a Managing Partner at Datago SA, Alexis has been instrumental in developing comprehensive data protection solutions for organizations. As an external Data Protection Officer for multiple companies, including AC Immune and AB2 Bio Ltd., Alexis ensures compliance with data protection regulations. Additional roles include Managing Director of Optyma Sarl, a Swiss consulting firm, and former CEO of PRAGMANTIC S.A., where leadership led to significant organizational transformation. Alexis's educational background includes advanced studies in Board Management and Data Protection, underscoring a solid foundation in business administration and risk management.
This person is not in any teams
This person is not in any offices
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.